Chinese PLA General Hospital
China's military flagship hospital, known in oncology for early CAR-T and gene-edited T-cell trials, minimally invasive liver surgery and nuclear medicine.
Overview
The Chinese PLA General Hospital, commonly called 301 Hospital, is the largest military hospital in China and a comprehensive tertiary centre in Beijing. Its Department of Bio-therapeutics under Weidong Han ran some of the earliest Chinese CAR-T and CRISPR-edited T-cell studies in lymphoma and solid tumours, and its haematology, hepatobiliary surgery (including laparoscopic and robotic hepatectomy), urology and interventional radiology departments are national leaders. The hospital has a large PET/CT and nuclear medicine service and serves as a national referral centre for complex cases from across China.
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-10-22.
Matched to Chinese PLA General Hospital, including child institutions. 1,257 works · 11,282 citations · 78% open access · 10% clinical trials · 2% reviews.
- Guanghai Dai45 works
- Yi Hu39 works
- Weidong Han37 works
- Rong Liu35 works
- Zefei Jiang34 works
- Zhikuan Wang27 works
- Jianming Xu24 works
- Enqiang Linghu19 works
- Yueyin Pan18 works
- Haitao Tao17 works
- CAR-T and gene-edited T-cell trials
- Hepatobiliary and robotic surgery
- Nuclear medicine
- Haematology
Similar pages
not linked directly; found by shared links- InstitutionMayo Clinic
Shares Diffuse large B-cell lymphoma, Hepatocellular carcinoma.
- TrialInvestigating the Safety and Diagnostic Performance of 68Ga-NYM032 Injection PET/CT in Men With Newly Diagnosed Prostate Cancer.
Shares PET/CT, Prostate cancer.
- TrialThis Study Evaluates the Diagnostic Performance and Safety of 68Ga-NYM032 PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer.
Shares PET/CT, Prostate cancer.
- TrialBiodistribution and Dosimetry of Ga-68 P16-093 in Prostate Cancer
Shares PET/CT, Prostate cancer.
- InstitutionQST Hospital (National Institutes for Quantum Science and Technology)
Shares Hepatocellular carcinoma, Prostate cancer.
- TrialStudy of 18F-Florastamin PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer
Shares PET/CT, Prostate cancer.
- OpportunityGPC3 imaging of the indeterminate liver nodule, led from China
Shares Hepatocellular carcinoma, PET/CT.
- IdeaQualify PSMA PET tumour volume as a validated imaging biomarker
Shares PET/CT, Prostate cancer.